Common misconceptions

Common mistake
Wrong: A silent mutation always changes the amino acid to one with similar properties.
Right: A silent mutation changes the codon but encodes the exact same amino acid due to codon degeneracy; the protein sequence is unchanged.
A silent mutation changes the DNA nucleotide and the codon sequence, but because the genetic code is degenerate — multiple codons encode the same amino acid — the resulting protein is completely unchanged. This is fundamentally different from a conservative missense mutation, where the amino acid does change but to one with similar biochemical properties (e.g., Val→Ala). The key distinction: silent = identical protein; conservative missense = similar but not identical amino acid.
Common mistake
Wrong: A single-nucleotide substitution is more severe than a single-nucleotide insertion or deletion.
Right: A single-nucleotide insertion or deletion causes a frameshift that alters every downstream amino acid, making it generally more severe than a point substitution.
A single nucleotide insertion or deletion disrupts the reading frame for every codon downstream, effectively scrambling the entire C-terminal portion of the protein and often introducing a premature stop codon. A point substitution (single nucleotide change without insertion or deletion) only alters one codon — the rest of the protein remains intact. This is why frameshifts are generally more severe: the damage is not local, it's global.
Common mistake
Wrong: Sickle cell disease is caused by a nonsense mutation.
Right: Sickle cell disease is caused by a missense mutation (Glu→Val at position 6 of beta-globin); nonsense mutations introduce a premature stop codon.
Sickle cell disease comes from a missense mutation — glutamate (a charged, hydrophilic residue) is replaced by valine (a nonpolar, hydrophobic residue) at position 6 of the beta-globin chain. This single amino acid swap changes the protein's surface chemistry and causes HbS polymerization under low oxygen. A nonsense mutation would instead introduce a premature UAA, UAG, or UGA stop codon, truncating the protein — a very different pathophysiology.
Common mistake
Gap: Missing the downstream consequence of splice-site mutations on mRNA and protein
Splice-site mutations cause retention of introns or skipping of exons, producing an abnormal protein and often triggering nonsense-mediated decay.
Splice-site mutations disrupt the conserved GT-AG dinucleotides (or nearby branch point) that the spliceosome recognizes to remove introns. The result is either intron retention (intronic sequence stays in the mRNA) or exon skipping (an exon is excluded). Either way, the reading frame is often disrupted or an aberrant protein is produced — and critically, many of these abnormal transcripts are degraded by nonsense-mediated decay, meaning the net effect is reduced or absent protein, not just a structurally altered one.
Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →
Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

  1. Define each mutation type precisely: silent (same amino acid), missense (different amino acid), nonsense (premature stop codon), frameshift (reading frame disruption from insertions/deletions), and splice-site (altered intron-exon boundary processing).
  2. Rank mutation types by severity and explain the mechanism behind that ranking — specifically why frameshifts and nonsense mutations are generally more severe than missense mutations, and why missense severity depends on the chemical properties of the substituted amino acid.
  3. Identify the mutation type underlying classic disease examples: sickle cell disease (missense, Glu→Val), Duchenne muscular dystrophy (frameshift), beta-thalassemia (splice-site), and familial hypercholesterolemia or other truncating diseases (nonsense).

Can you avoid these mistakes?

A point mutation changes codon 39 of a beta-globin gene from CAG to UAG. What type of mutation is this, and what is the most likely consequence for the protein?
A patient has Duchenne muscular dystrophy caused by a 2-nucleotide deletion in the dystrophin gene. Why does a 2-nucleotide deletion cause a more severe phenotype than a 3-nucleotide deletion in the same gene?
Two mutations both change a single nucleotide in the coding region of a gene. Mutation A changes the amino acid; Mutation B does not. What is the molecular explanation for why Mutation B leaves the protein unchanged, and what do you call each mutation type?
A splice-site mutation is identified at the 5' donor site of intron 6 in a gene. A classmate says this will produce a slightly abnormal protein. What additional consequence should you tell them to consider, and why does it matter for predicting the patient's phenotype?

Related topics

See how your Anki deck covers this topic.

Upload your deck for a free audit →